PERRY MICHAEL S 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Dec 20, 2024
Insider Transaction Report
Form 4
PERRY MICHAEL S
Director
Transactions
- Award
Common Stock
2024-12-18$22.99/sh+16,733$384,692→ 131,490 total
Footnotes (1)
- [F1]Represents shares underlying restricted stock units, which shares will vest in one installment on the first anniversary date.